TCI > Innovations > Scientific Publications > Bifidobacterium lactis ameliorates AOM/DSS-induced inflammation, dysbiosis, and colonic precancerous lesions
Bifidobacterium lactis ameliorates AOM/DSS-induced inflammation, dysbiosis, and colonic precancerous lesions
Scientific Publications

Bifidobacterium lactis ameliorates AOM/DSS-induced inflammation, dysbiosis, and colonic precancerous lesions

Paper Title

Bifidobacterium lactis ameliorates AOM/DSS-induced inflammation, dysbiosis, and colonic precancerous lesions

IngredientTCI604 Bifidobacterium lactis
BenefitGut Health
Study TypeAnimal Study
JournalApplied Microbiology and Biotechnology. 2025; 109:69
DOI: 10.1007/s00253-025-13445-x

* This page summarizes a study published by TCI in a peer-reviewed journal. Please refer to the original journal for full details.